» Articles » PMID: 1634773

Human Leukocyte Activation Antigen M6, a Member of the Ig Superfamily, is the Species Homologue of Rat OX-47, Mouse Basigin, and Chicken HT7 Molecule

Overview
Journal J Immunol
Date 1992 Aug 1
PMID 1634773
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral granulocytes from rheumatoid arthritis and reactive arthritis patients were recently found to express higher levels of a newly defined Ag, termed M6, in comparison to granulocytes from healthy subjects. We present here the molecular characterization of M6 Ag and show that it is a novel human leukocyte activation-associated cell surface glycoprotein. Peripheral lymphocytes do not significantly express M6 Ag, however, it appears upon 3-day PHA-activated T blasts. On monocytes, which constitutively express M6 Ag, it is down-regulated on day 1 but re-induced on day 3 of granulocyte-macrophage CSF stimulation. SDS-PAGE analysis of M6 immunoprecipitates shows a single band of 54 kDa under nonreducing conditions that shifts to 65 kDa under reducing conditions. Endoglycosidase F treatment of M6 immunoprecipitate reveals that 50% of the M6 molecule is composed of N-linked carbohydrates. By modifying the COS cell cloning strategy, we have isolated cDNA clones encoding M6 Ag. M6 cDNA hybridizes with a single mRNA transcript of approximately 1.7 kb in Northern blotting. Comparison analysis of the M6 sequence indicates that M6 Ag is a member of the Ig superfamily and the species homologue of rat OX-47 Ag, mouse basigin (gp42), and chicken HT7 molecule. The highly conserved remarkable transmembrane domain suggests that the M6 Ag may be a component of a multichain complex in the plasma membrane.

Citing Articles

Cyclophilin-CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8.

Tajti G, Gebetsberger L, Pamlitschka G, Aigner-Radakovics K, Leitner J, Steinberger P Front Immunol. 2025; 16:1460089.

PMID: 39963132 PMC: 11830813. DOI: 10.3389/fimmu.2025.1460089.


Immunohistochemical Detection of CD147 Expression in Adenocarcinoma of the Prostate: A Case-Control Study.

Suliman S, Ellaithi M Prostate Cancer. 2024; 2024:4406057.

PMID: 39735939 PMC: 11682863. DOI: 10.1155/proc/4406057.


Metabolic Function and Therapeutic Potential of CD147 for Hematological Malignancies: An Overview.

Spinello I, Labbaye C, Saulle E Int J Mol Sci. 2024; 25(17).

PMID: 39273126 PMC: 11395103. DOI: 10.3390/ijms25179178.


SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.

Shouman S, El-Kholy N, Hussien A, El-Derby A, Magdy S, Abou-Shanab A Cell Commun Signal. 2024; 22(1):349.

PMID: 38965547 PMC: 11223399. DOI: 10.1186/s12964-024-01718-3.


CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.

Kanekura T Int J Mol Sci. 2023; 24(24).

PMID: 38139173 PMC: 10743398. DOI: 10.3390/ijms242417344.